J. Kruining

504 total citations
18 papers, 417 citations indexed

About

J. Kruining is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, J. Kruining has authored 18 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in J. Kruining's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers) and Hepatitis Viruses Studies and Epidemiology (5 papers). J. Kruining is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers) and Hepatitis Viruses Studies and Epidemiology (5 papers). J. Kruining collaborates with scholars based in Netherlands, Belgium and United States. J. Kruining's co-authors include R. A. Heijtink, Solko W. Schalm, Erik De Clercq, Jan Balzarini, Rudolf A. Heijtink, Christopher McGuigan, Antonı́n Holý, Jan Balzarini, L Berk and Heidi Pelemans and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

J. Kruining

17 papers receiving 395 citations

Peers

J. Kruining

EPIDE

HEPAT

ID

MB

VIROL

Lance C. Johnson United States

Erika Cretton-Scott United States

Wendy Mostmans Belgium

Annick Scholliers United States

Monica Bisbocci Italy

Andrew Bae United States

Silke Offensperger Germany

Florence Myrick United States

Marina Taliani Italy

Fang Guo China

Lance C. Johnson United States

J. Kruining

509 ×1.6

EPIDE

450 ×2.1

HEPAT

357 ×1.8

ID

116 ×1.2

MB

71 ×1.0

VIROL

Citations per year, relative to J. Kruining J. Kruining (= 1×) peers Lance C. Johnson

Countries citing papers authored by J. Kruining

Since Specialization

Citations

This map shows the geographic impact of J. Kruining's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Kruining with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Kruining more than expected).

Fields of papers citing papers by J. Kruining

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Kruining. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Kruining. The network helps show where J. Kruining may publish in the future.

Co-authorship network of co-authors of J. Kruining

This figure shows the co-authorship network connecting the top 25 collaborators of J. Kruining. A scholar is included among the top collaborators of J. Kruining based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Kruining. J. Kruining is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Heijtink, R. A., et al.. (2002). Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant‐DNA hepatitis B vaccine. Journal of Medical Virology. 66(3). 304–311. 5 indexed citations

2.

Balzarini, Jan, J. Kruining, Christophe Pannecouque, et al.. (1997). Conversion of 2′,3′‐dideoxyadenosine (ddA) and 2′,3′‐didehydro‐2′,3′‐dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. FEBS Letters. 410(2-3). 324–328. 53 indexed citations

3.

Heijtink, Rudolf A., J. Kruining, Pieter Honkoop, et al.. (1997). Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B. Journal of Medical Virology. 53(3). 282–287. 2 indexed citations

4.

Heijtink, Rudolf A., J. Kruining, Pieter Honkoop, et al.. (1997). Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B. Journal of Medical Virology. 53(3). 282–287. 31 indexed citations

5.

Balzarini, Jan, J. Kruining, Heidi Pelemans, et al.. (1996). Anti-HIV and Anti-HBV Activity and Resistance Profile of 2′,3′-Dideoxy-3′-Thiacytidine (3TC) and Its Arylphosphoramidate Derivative CF 1109. Biochemical and Biophysical Research Communications. 225(2). 363–369. 50 indexed citations

6.

Kruining, J., Rudolf A. Heijtink, & Solko W. Schalm. (1995). Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment. Journal of Hepatology. 22(3). 263–267. 31 indexed citations

7.

Heijtink, R. A., et al.. (1995). Quantitative measurement of HBeAg in chronic hepatitis B: A comparison between a radioimmunoassay a fluorescence ELISA and a chemiluminescence ELISA. Journal of Medical Virology. 47(3). 245–250. 5 indexed citations

8.

Heijtink, Rudolf A., et al.. (1995). Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an “inhibition in solution” assay. Hepatology. 22(4). 1078–1083. 19 indexed citations

9.

Heijtink, R. A., et al.. (1994). Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture. Antimicrobial Agents and Chemotherapy. 38(9). 2180–2182. 73 indexed citations

10.

Balzarini, Jan, J. Kruining, R. A. Heijtink, & Erik De Clercq. (1994). Comparative Anti-Retrovirus and Anti-Hepadnavirus Activity of Three Different Classes of Nucleoside Phosphonate Derivatives. Antiviral chemistry & chemotherapy. 5(6). 360–365. 10 indexed citations

11.

Heijtink, R. A., J. Kruining, L Berk, et al.. (1993). Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) on human and duck hepatitis B virus infection. Antiviral Research. 21(2). 141–153. 97 indexed citations

12.

Heijtink, R. A., et al.. (1989). Anti-pre-S(2) analysis after hepatitis B vaccination in haemodialysis patients. Antiviral Research. 12(2). 75–86. 2 indexed citations

13.

Kruining, J., Paul Mulder, & R. A. Heijtink. (1988). Immune response to HBsAg differently interpreted by RIA and EIA. Journal of Virological Methods. 22(1). 89–98. 2 indexed citations

14.

Heijtink, R. A., et al.. (1987). Detection of HBV-DNA in liver biopsy and serum: Its significance in the selection of hepatitis B patients for antiviral therapy. Antiviral Research. 7(6). 329–340. 10 indexed citations

15.

Kruining, J., et al.. (1987). Hepatitis B vaccination in health care workers: assessment of simple guidelines.. PubMed. 30(3-4). 117–27. 3 indexed citations

16.

Heijtink, R. A., J. Kruining, Marleen Bakker, & Solko W. Schalm. (1985). Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine. Antiviral Research. 5. 273–279. 19 indexed citations

17.

Heijtink, R. A., J. Kruining, Solko W. Schalm, & N. Masurel. (1985). Comparison of two techniques for detecting antibody to HBsAg during a hepatitis B vaccine study. Journal of Virological Methods. 10(4). 333–339. 4 indexed citations

18.

Heijtink, R. A., et al.. (1983). Vaccination against hepatitis B: prescreening and follow-up by an ELISA detecting both HBsAg and anti-HBs. Antonie van Leeuwenhoek. 49(6). 601–601. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact